GE Healthcare Ltd. et al. v. The Johns Hopkins University et al.

PGR2025-00059

GE Healthcare petitions to invalidate Johns Hopkins' U.S. Patent 12,115,233 covering FAP‑targeting radiopharmaceuticals, asserting obviousness, lack of written description, and lack of enablement.

Jurisdiction
US PTAB
Case Number
PGR2025-00059
Decision Date
14 July 2025
Filing Date
14 July 2025

Detailed Summary

In a petition for post‑grant review (PGR2025‑00059), GE Healthcare Ltd. challenges U.S. Patent No. 12,115,233 owned by Johns Hopkins University. The petitioner contends that claims 1‑4 are obvious in view of US‑633 combined with Meletta and Jansen, and also in view of US‑121 together with Jansen. Additionally, the petition argues that the specification fails to provide a sufficient written description and does not enable the claimed breadth of low‑molecular‑weight FAP‑targeting compounds, which number in the billions. The Board is urged to institute trial and cancel the claims.

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in GE Healthcare Ltd. et al. vs The Johns Hopkins University et al. is valuable context for structuring arguments or assessing risk in similar proceedings.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call